Tuesday, October 13, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Banking & Insurance

XRP’s On-Chain Activity Plummets Despite Ripple’s Institutional Progress

SiterGedge by SiterGedge
February 21, 2026
in Banking & Insurance, Blockchain, Ethereum & Altcoins
0
XRP Stock
0
SHARES
49
VIEWS
Share on FacebookShare on Twitter

A significant expansion of Deutsche Bank’s collaboration with Ripple Labs marks a milestone for the blockchain firm, highlighting growing institutional adoption of its technology. However, a closer examination reveals a critical divergence: the banking giant is implementing Ripple’s blockchain solutions but is not utilizing the XRP cryptocurrency within its operations. This distinction comes as activity on the XRP network itself experiences a severe contraction.

Network Engagement Crashes

Data from blockchain analyst Ali Martinez underscores a stark decline in user engagement on the XRP ledger. Over a seven-day period, the number of active addresses plummeted by approximately 26%, falling from 55,080 to 40,778. This sharp drop signals waning interest from retail participants and points to decreasing transaction volumes on the network. The positive news flow surrounding corporate partnerships is not reflected in the on-chain metrics, revealing a disconnect between institutional deals and ecosystem vitality.

Adoption Without the Asset

Deutsche Bank’s strategy focuses on leveraging Ripple’s enterprise-grade, blockchain-based software to modernize legacy payment infrastructures. The objectives are to reduce settlement times from days to seconds and to cut operational costs for cross-border transfers by up to 30%.

Should investors sell immediately? Or is it worth buying XRP?

Critically, this partnership utilizes Ripple’s private ledger technology and enterprise software suite. It does not employ the “On-Demand Liquidity” service, which specifically uses XRP as a bridge currency for liquidity. The bank is facilitating fiat-to-fiat transactions via blockchain rails, completely bypassing the need for the XRP token. For investors, this delineation is crucial—institutional acceptance of the underlying technology does not inherently translate into direct demand for the associated digital asset.

Price Feels the Strain

The growing chasm between technological adoption and token utility is applying downward pressure on XRP’s market valuation. The cryptocurrency has breached a key support level at $1.50 and is currently trading around $1.42. Market experts note that major financial institutions, including Standard Chartered, have revised their long-term price targets for XRP downward. This trend is viewed as evidence that the market is increasingly distinguishing between Ripple’s success as a software provider and the fundamental demand drivers for the XRP token.

Ad

XRP Stock: Buy or Sell?! New XRP Analysis from October 13 delivers the answer:

The latest XRP figures speak for themselves: Urgent action needed for XRP investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 13.

XRP: Buy or sell? Read more here...

Tags: XRP
SiterGedge

SiterGedge

Related Posts

Commerzbank Stock
Banking & Insurance

Commerzbank’s CEO Puts a Price on Her Future as UniCredit Circles Closer

September 7, 2026
Münchener Rück Stock
Analysis

Munich Re’s Monte Carlo Warning Collides With Wall Street’s Widest Analyst Split in Years

September 7, 2026
Münchener Rück Stock
Banking & Insurance

Munich Re’s Calendar Tightens: Cyber Deal, Analyst Divergence and a Q3 Reckoning on the Horizon

September 6, 2026
Next Post
GRI Bio Stock

GRI Bio's Financial Runway Extends to 2027 Amid Clinical Push

Tilray Stock

Tilray Secures Exclusive U.S. Rights for Carlsberg Beer Portfolio

Ultragenyx Pharmaceutical Stock

Divergent Analyst Views Highlight Ultragenyx's Crossroads

Recommended

Tesla Stock

Tesla’s AI Ambitions Face Reality Check Amid Operational Hurdles

10 months ago
Franklin Covey Stock

Franklin Covey Shares Face Critical Test Amid Steep Decline

12 months ago
High Content Screening

Unlocking the Future of Medicine: The Rise of High Content Screening in Biologics Discovery

3 years ago
Circle Stock

Circle’s Strategic Push into Emerging Markets Amid Share Price Volatility

7 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

OpenAI’s Miss Exposes AI’s Debt Load as Yields Climb

Banks Slump 13% Ahead of Profit Gains of Up to 20%

Records on Narrow Shoulders as the 10-Year Yield Tops 5.3%

PepsiCo and Delta Put the US Consumer to the Test as Stocks Hit Records

Cash Flow Beats Backlog as Banks Brace for Earnings

Q4 Stock Picking: Where Scarcity Is Priced In, and Where It Isn’t

Trending

OpenAI Stock
Newsletter

Goldman Delivers as Memory Stocks Slide Ahead of CPI

by Stephanie Dugan
October 13, 2026
0

Dear readers, Goldman Sachs beat profit expectations by roughly $4 a share on Tuesday, and it still...

Lumentum Stock

Optics Run Hot as Chip Leaders Pause for Breath

October 12, 2026
Humana Stock

SpaceX Hits the Carriers, Medicare Stars Lift Humana

October 10, 2026
TSMC Stock

OpenAI’s Miss Exposes AI’s Debt Load as Yields Climb

October 9, 2026
Bank of America Stock

Banks Slump 13% Ahead of Profit Gains of Up to 20%

October 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Goldman Delivers as Memory Stocks Slide Ahead of CPI
  • Optics Run Hot as Chip Leaders Pause for Breath
  • SpaceX Hits the Carriers, Medicare Stars Lift Humana

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com